Gold prices hit 2-week high as Trump-Fed feud escalates with Cook firing
SEATTLE—Emily Dreyer, the Senior Vice President of Channel Growth at Trupanion, Inc. (NASDAQ:TRUP), has sold a significant portion of the company’s common stock, according to a recent SEC filing. On March 7, Dreyer sold a total of 14,025 shares at prices ranging from $32.4126 to $32.4136 per share, amounting to approximately $454,590. According to InvestingPro data, the stock has shown significant volatility, with shares trading 43% below their 52-week high of $57.90.
Alongside these sales, Dreyer also exercised stock options to acquire shares. The transactions involved acquiring a total of 10,654 shares at prices between $7.78 and $17.97, valued at approximately $172,871. Following these transactions, Dreyer holds 27,645 shares in Trupanion. The company, currently valued at $1.4 billion, has seen its revenue grow by 16% over the last twelve months, though analysts expect more modest growth of 8% next year.
Trupanion, a Seattle-based company, specializes in medical insurance for pets, providing coverage for unexpected illnesses and injuries. While the company currently operates at a loss, InvestingPro analysis suggests potential profitability this year, with analysts maintaining a positive outlook. InvestingPro subscribers have access to 12 additional key insights about TRUP’s financial health and market position.
In other recent news, Trupanion Inc . reported its fourth-quarter 2024 earnings, revealing a slight miss on earnings per share (EPS) compared to analyst forecasts. The company posted an EPS of $0.04, falling short of the projected $0.07. However, revenue slightly surpassed expectations, reaching $337.3 million against a forecast of $335.46 million, marking a 14% year-over-year increase. Subscription revenue grew 19% to $227.8 million, contributing to the company’s total adjusted operating income, which rose by 30% to $35.8 million.
Stifel analysts revised their price target for Trupanion stock, lowering it to $41 from $44, while retaining a Hold rating. This adjustment followed the company’s fourth-quarter performance, which saw EBITDA and free cash flow exceeding expectations, but also highlighted concerns over retention rates and subscriber growth. Piper Sandler also adjusted its outlook, reducing the price target to $52 from $57, but maintained an Overweight rating. The firm noted Trupanion’s achievements, such as a 70% loss ratio and 15.3% adjusted operating margin, but mentioned a slowdown in subscription growth.
Trupanion faced challenges with subscriber growth, reporting a 10% decline in new subscribers year-over-year. The company also wrote off approximately $5.3 million in goodwill related to acquisitions in Europe, specifically Smart Paws and PetExpert. Despite these challenges, Trupanion remains optimistic about its long-term growth, projecting 2025 revenue between $1.379 billion and $1.414 billion, with plans to increase pet acquisition spending and expand its international presence.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.